Revenue - Qingdao Baheal Medical Inc (SZSE:301015) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 33.29 CNY 0.39%

Updated:

Qingdao Baheal Medical Inc
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Qingdao Baheal Medical Inc
Revenue Peer Comparison

1099

601607

600998

C

600511

000963

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
Q	Qingdao Baheal Medical Inc SZSE:301015	Revenue ¥7.6B	CAGR 3-Years 9%	CAGR 5-Years 16%	CAGR 10-Years N/A
	Sinopharm Group Co Ltd HKEX:1099	Revenue ¥596.6B	CAGR 3-Years 9%	CAGR 5-Years 12%	CAGR 10-Years 14%
	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Revenue ¥264.2B	CAGR 3-Years 9%	CAGR 5-Years 9%	CAGR 10-Years 13%
	Jointown Pharmaceutical Group Co Ltd SSE:600998	Revenue ¥148.5B	CAGR 3-Years 8%	CAGR 5-Years 11%	CAGR 10-Years 16%
C	China National Medicines Corp Ltd SSE:600511	Revenue ¥50.6B	CAGR 3-Years 6%	CAGR 5-Years 5%	CAGR 10-Years 17%
	Huadong Medicine Co Ltd SZSE:000963	Revenue ¥40.9B	CAGR 3-Years 6%	CAGR 5-Years 5%	CAGR 10-Years 9%

See Also

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Revenue amounts to 7.6B CNY.

Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Qingdao Baheal Medical Inc have been 9% over the past three years , 16% over the past five years .

Join more than 139,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.